Matching-adjusted indirect comparison between garadacimab and lanadelumab for the long-term prophylactic treatment of patients with hereditary angioedema.
- DOI
- 10.57264/cer-2024-0237
- Published
- 2025 Aug
- Container
- Journal of comparative effectiveness research
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.57264/cer-2024-0237,
title = {Matching-adjusted indirect comparison between garadacimab and lanadelumab for the long-term prophylactic treatment of patients with hereditary angioedema.},
author = {Walsh S and Haltner A and Bartlett M and Sears J and Li Y and Kelly M and Gavata-Steiger S and Nenci C and Jacobs I and Pragst I and Ray N and Samjoo IA},
year = {2025},
journal = {Journal of comparative effectiveness research},
doi = {10.57264/cer-2024-0237},
url = {https://doi.org/10.57264/cer-2024-0237}
}RIS
TY - JOUR TI - Matching-adjusted indirect comparison between garadacimab and lanadelumab for the long-term prophylactic treatment of patients with hereditary angioedema. AU - Walsh S AU - Haltner A AU - Bartlett M AU - Sears J AU - Li Y AU - Kelly M AU - Gavata-Steiger S AU - Nenci C AU - Jacobs I AU - Pragst I AU - Ray N AU - Samjoo IA PY - 2025 JO - Journal of comparative effectiveness research DO - 10.57264/cer-2024-0237 UR - https://doi.org/10.57264/cer-2024-0237 ER -
APA
S, W., A, H., M, B., J, S., Y, L., M, K., S, G., C, N., I, J., I, P., N, R., & IA, S. (2025). Matching-adjusted indirect comparison between garadacimab and lanadelumab for the long-term prophylactic treatment of patients with hereditary angioedema.. Journal of comparative effectiveness research. https://doi.org/10.57264/cer-2024-0237
Source records
- pubmed · retrieved 2026-09-26T09:17:22.148Z